Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer
暂无分享,去创建一个
S. Fox | J. Visvader | H. Clevers | G. Smyth | Norman Sachs | G. Lindeman | Huiling Xu | F. Vaillant | A. Fellowes | J. Dekkers | M. Herold | A. Policheni | D. Gray | Göknur Giner | James R. Whittle | Bianca D. Capaldo | He K. Liu | Elliot E. Surgenor | Huei-Rong Chen | Thomas Green | J. Whittle